Stephen Huhn
Chief Tech/Sci/R&D Officer at CONTINEUM THERAPEUTICS, INC.
Net worth: - $ as of 30/05/2024
Stephen Huhn active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2019 | - |
Career history of Stephen Huhn
Former positions of Stephen Huhn
| Companies | Position | Start | End |
|---|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Chief Tech/Sci/R&D Officer | 16/06/2014 | 31/12/2015 |
| Corporate Officer/Principal | 31/12/2006 | 16/06/2014 | |
| Stanford University | Corporate Officer/Principal | - | - |
Training of Stephen Huhn
| University of Arizona | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
- Stock Market
- Insiders
- Stephen Huhn
- Experience